ISG15 as a novel tumor biomarker for drug sensitivity
Shyamal D. Desai, Leroy F. Liu(Rutgers, The State University of New Jersey), Yu‐Chen Tsai, Jeffrey R. Marks(Duke Medical Center), Beppino C. Giovanella(Christus Stehlin Foundation for Cancer Research), Laurence M. Wood(Texas Tech University), Georgia L. Scott(Duke Medical Center), Tao‐shih Hsieh(Institute of Cytochemistry and Molecular Pharmacology)
Cited by 71
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Topoisomerase II is a structural component of mitotic chromosome scaffolds.
|The Journal of Cell Biology|1985|760